Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle, Skeletal | 18 | 2024 | 4980 | 1.730 |
Why?
|
Regeneration | 9 | 2024 | 1524 | 1.670 |
Why?
|
Muscular Diseases | 3 | 2023 | 555 | 1.660 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2023 | 124 | 1.130 |
Why?
|
Tissue Scaffolds | 7 | 2024 | 951 | 0.960 |
Why?
|
Teichoic Acids | 1 | 2024 | 70 | 0.910 |
Why?
|
Wound Healing | 6 | 2024 | 2815 | 0.890 |
Why?
|
Musculoskeletal Physiological Phenomena | 1 | 2023 | 31 | 0.870 |
Why?
|
Burns | 10 | 2018 | 1901 | 0.840 |
Why?
|
Rhytidoplasty | 1 | 2024 | 72 | 0.840 |
Why?
|
Mammaplasty | 6 | 2023 | 1263 | 0.760 |
Why?
|
Muscle Development | 6 | 2020 | 258 | 0.750 |
Why?
|
Sarcopenia | 3 | 2023 | 377 | 0.730 |
Why?
|
Mastectomy | 4 | 2023 | 1850 | 0.720 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 37 | 0.720 |
Why?
|
Skin Transplantation | 5 | 2018 | 1097 | 0.700 |
Why?
|
Contracture | 3 | 2024 | 236 | 0.700 |
Why?
|
Surgical Wound Infection | 3 | 2018 | 1546 | 0.680 |
Why?
|
Fibrosis | 6 | 2023 | 2081 | 0.670 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 88 | 0.640 |
Why?
|
Nanostructures | 1 | 2024 | 553 | 0.640 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2006 | 1252 | 0.610 |
Why?
|
Occlusive Dressings | 1 | 2018 | 52 | 0.610 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 157 | 0.600 |
Why?
|
Surgical Flaps | 7 | 2023 | 1682 | 0.600 |
Why?
|
Breast Implantation | 2 | 2017 | 225 | 0.570 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 1942 | 0.570 |
Why?
|
Chitosan | 1 | 2018 | 141 | 0.550 |
Why?
|
Matrix Metalloproteinase 9 | 7 | 2006 | 633 | 0.540 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2222 | 0.540 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3518 | 0.510 |
Why?
|
Matrix Metalloproteinase 2 | 4 | 2006 | 462 | 0.490 |
Why?
|
Facial Transplantation | 4 | 2021 | 222 | 0.470 |
Why?
|
Parabiosis | 1 | 2014 | 65 | 0.460 |
Why?
|
Pancreatic Elastase | 6 | 2006 | 125 | 0.410 |
Why?
|
Tissue Engineering | 5 | 2024 | 1893 | 0.410 |
Why?
|
Immunity, Innate | 2 | 2024 | 3080 | 0.400 |
Why?
|
Cartoons as Topic | 1 | 2011 | 13 | 0.380 |
Why?
|
Osteosarcoma | 1 | 2016 | 911 | 0.340 |
Why?
|
Animals | 40 | 2024 | 169408 | 0.340 |
Why?
|
Recovery of Function | 2 | 2019 | 2990 | 0.330 |
Why?
|
Aging | 6 | 2023 | 8765 | 0.320 |
Why?
|
Glycosaminoglycans | 2 | 2023 | 611 | 0.310 |
Why?
|
Cell Cycle | 1 | 2016 | 2937 | 0.290 |
Why?
|
Mice | 23 | 2024 | 82074 | 0.290 |
Why?
|
Breast Implants | 2 | 2024 | 414 | 0.290 |
Why?
|
Child Welfare | 1 | 2011 | 523 | 0.280 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2018 | 553 | 0.270 |
Why?
|
Rats, Sprague-Dawley | 9 | 2023 | 8200 | 0.270 |
Why?
|
Gene Expression Profiling | 4 | 2020 | 9549 | 0.260 |
Why?
|
Breast | 1 | 2015 | 1976 | 0.260 |
Why?
|
Nitroso Compounds | 1 | 2006 | 71 | 0.260 |
Why?
|
Testosterone | 2 | 2014 | 2494 | 0.250 |
Why?
|
Nitric Oxide Donors | 1 | 2006 | 126 | 0.250 |
Why?
|
Facial Injuries | 2 | 2017 | 191 | 0.250 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1169 | 0.230 |
Why?
|
Health Education | 1 | 2011 | 1059 | 0.230 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2023 | 750 | 0.230 |
Why?
|
Muscular Atrophy | 2 | 2024 | 335 | 0.230 |
Why?
|
Postoperative Complications | 4 | 2024 | 15889 | 0.230 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 595 | 0.230 |
Why?
|
Cell Movement | 4 | 2018 | 5216 | 0.220 |
Why?
|
Muscle Strength | 2 | 2019 | 641 | 0.220 |
Why?
|
Adipose Tissue | 1 | 2016 | 3335 | 0.220 |
Why?
|
Cell Proliferation | 2 | 2017 | 10486 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2565 | 0.220 |
Why?
|
Collagen | 2 | 2023 | 2646 | 0.210 |
Why?
|
Organ Size | 3 | 2019 | 2268 | 0.210 |
Why?
|
Rats | 11 | 2023 | 23847 | 0.210 |
Why?
|
Rejuvenation | 1 | 2024 | 110 | 0.200 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 385 | 0.200 |
Why?
|
NF-kappa B | 2 | 2024 | 2492 | 0.200 |
Why?
|
Polyesters | 1 | 2024 | 377 | 0.200 |
Why?
|
Porosity | 1 | 2023 | 352 | 0.200 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.190 |
Why?
|
Mice, Inbred C57BL | 7 | 2023 | 22381 | 0.190 |
Why?
|
Surgery, Plastic | 3 | 2016 | 651 | 0.190 |
Why?
|
India | 5 | 2016 | 2325 | 0.190 |
Why?
|
Estrogen Receptor beta | 1 | 2022 | 171 | 0.190 |
Why?
|
Breast Neoplasms | 7 | 2023 | 21187 | 0.190 |
Why?
|
Disease Models, Animal | 8 | 2024 | 18366 | 0.170 |
Why?
|
Cicatrix | 2 | 2024 | 799 | 0.170 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2517 | 0.170 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 533 | 0.160 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2006 | 709 | 0.160 |
Why?
|
Signal Transduction | 6 | 2024 | 23652 | 0.160 |
Why?
|
Health Promotion | 1 | 2011 | 2210 | 0.160 |
Why?
|
Hematoma | 1 | 2024 | 768 | 0.160 |
Why?
|
Skin Pigmentation | 1 | 2021 | 281 | 0.160 |
Why?
|
Neuromuscular Junction | 1 | 2021 | 407 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1337 | 0.150 |
Why?
|
Leukocytes | 1 | 2006 | 2034 | 0.150 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 89 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 581 | 0.150 |
Why?
|
Replantation | 1 | 2018 | 145 | 0.140 |
Why?
|
Lymphedema | 1 | 2023 | 526 | 0.140 |
Why?
|
Rectus Abdominis | 2 | 2023 | 102 | 0.140 |
Why?
|
Thyroid Hormone Receptors alpha | 1 | 2016 | 13 | 0.130 |
Why?
|
Fetus | 2 | 2014 | 1882 | 0.130 |
Why?
|
Sex Characteristics | 1 | 2006 | 2660 | 0.130 |
Why?
|
GABA-A Receptor Antagonists | 1 | 2016 | 59 | 0.130 |
Why?
|
Pentylenetetrazole | 1 | 2016 | 72 | 0.130 |
Why?
|
Keratinocytes | 2 | 2018 | 876 | 0.130 |
Why?
|
Nutritional Requirements | 1 | 2017 | 279 | 0.130 |
Why?
|
Oxidative Stress | 1 | 2006 | 3138 | 0.120 |
Why?
|
Humans | 43 | 2024 | 768887 | 0.120 |
Why?
|
Transplantation, Homologous | 4 | 2021 | 4835 | 0.120 |
Why?
|
Aorta, Abdominal | 3 | 2006 | 627 | 0.120 |
Why?
|
rho-Associated Kinases | 1 | 2016 | 285 | 0.120 |
Why?
|
Organ Preservation | 1 | 2018 | 394 | 0.120 |
Why?
|
Hypertrophy | 2 | 2014 | 562 | 0.120 |
Why?
|
Time Factors | 6 | 2018 | 40266 | 0.120 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2126 | 0.110 |
Why?
|
Graft Survival | 4 | 2018 | 3888 | 0.110 |
Why?
|
Stem Cells | 3 | 2023 | 3540 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2015 | 447 | 0.110 |
Why?
|
Female | 26 | 2024 | 397464 | 0.110 |
Why?
|
Wrist Injuries | 1 | 2015 | 215 | 0.110 |
Why?
|
Neutrophil Infiltration | 2 | 2006 | 395 | 0.110 |
Why?
|
Apoptosis | 3 | 2022 | 9528 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 2016 | 407 | 0.100 |
Why?
|
Hand Injuries | 1 | 2015 | 240 | 0.100 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11934 | 0.100 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 518 | 0.100 |
Why?
|
Extremities | 1 | 2018 | 870 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2024 | 65485 | 0.100 |
Why?
|
Kerosene | 1 | 2012 | 15 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1891 | 0.100 |
Why?
|
Graft Rejection | 3 | 2021 | 4492 | 0.100 |
Why?
|
Cells, Cultured | 9 | 2018 | 19023 | 0.100 |
Why?
|
Enzyme Activation | 3 | 2009 | 3588 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1397 | 0.100 |
Why?
|
Mitochondria | 1 | 2005 | 3683 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7602 | 0.100 |
Why?
|
West Virginia | 1 | 2011 | 32 | 0.100 |
Why?
|
Postoperative Care | 1 | 2018 | 1481 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2024 | 14485 | 0.100 |
Why?
|
Cytokines | 1 | 2006 | 7453 | 0.090 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 577 | 0.090 |
Why?
|
Male | 24 | 2023 | 365249 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2017 | 804 | 0.090 |
Why?
|
Thoracic Wall | 1 | 2013 | 204 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2016 | 1105 | 0.090 |
Why?
|
Hypothyroidism | 1 | 2016 | 668 | 0.090 |
Why?
|
Workload | 1 | 2016 | 852 | 0.090 |
Why?
|
Perfusion | 3 | 2018 | 1402 | 0.090 |
Why?
|
Osteogenesis | 2 | 2014 | 1295 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2460 | 0.080 |
Why?
|
Fibroblasts | 2 | 2018 | 4178 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2018 | 2885 | 0.080 |
Why?
|
Irritants | 1 | 2009 | 43 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1045 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2016 | 1251 | 0.080 |
Why?
|
Dioxoles | 1 | 2009 | 96 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2014 | 751 | 0.080 |
Why?
|
Cell Line | 2 | 2020 | 15603 | 0.080 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 81 | 0.080 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2006 | 1493 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.080 |
Why?
|
Myostatin | 1 | 2009 | 129 | 0.080 |
Why?
|
Memory Disorders | 1 | 2016 | 1203 | 0.080 |
Why?
|
Skin Ulcer | 1 | 2009 | 130 | 0.080 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 440 | 0.070 |
Why?
|
Epigastric Arteries | 2 | 2023 | 93 | 0.070 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 173 | 0.070 |
Why?
|
Earthquakes | 1 | 2010 | 192 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1682 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8742 | 0.070 |
Why?
|
Child, Preschool | 6 | 2020 | 42684 | 0.070 |
Why?
|
Reading | 1 | 2011 | 543 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1436 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 947 | 0.070 |
Why?
|
Immunohistochemistry | 5 | 2014 | 11119 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1672 | 0.070 |
Why?
|
Cyclic N-Oxides | 1 | 2006 | 72 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2020 | 11684 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1658 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3811 | 0.070 |
Why?
|
Burn Units | 2 | 2017 | 143 | 0.060 |
Why?
|
Hydrogels | 2 | 2024 | 745 | 0.060 |
Why?
|
Bariatric Surgery | 1 | 2015 | 1001 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 425 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2905 | 0.060 |
Why?
|
Caspase 9 | 1 | 2005 | 184 | 0.060 |
Why?
|
Spin Labels | 1 | 2006 | 339 | 0.060 |
Why?
|
Matrix Metalloproteinases, Membrane-Associated | 1 | 2004 | 13 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13317 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1947 | 0.060 |
Why?
|
Developing Countries | 3 | 2012 | 2906 | 0.060 |
Why?
|
Catalase | 1 | 2005 | 215 | 0.060 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 796 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2005 | 131 | 0.060 |
Why?
|
Dilatation, Pathologic | 1 | 2006 | 527 | 0.060 |
Why?
|
Disasters | 1 | 2010 | 522 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8664 | 0.060 |
Why?
|
P-Selectin | 1 | 2006 | 599 | 0.060 |
Why?
|
RNA, Messenger | 4 | 2006 | 12809 | 0.060 |
Why?
|
Patient Satisfaction | 3 | 2013 | 3489 | 0.060 |
Why?
|
Adolescent | 6 | 2020 | 89247 | 0.060 |
Why?
|
Young Adult | 5 | 2017 | 60110 | 0.050 |
Why?
|
Adult | 10 | 2018 | 223818 | 0.050 |
Why?
|
Caspase 3 | 1 | 2005 | 731 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 742 | 0.050 |
Why?
|
Antigens, Ly | 1 | 2024 | 296 | 0.050 |
Why?
|
Caspases | 1 | 2005 | 881 | 0.050 |
Why?
|
Reoperation | 3 | 2021 | 4342 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1135 | 0.050 |
Why?
|
Schools | 1 | 2011 | 1498 | 0.050 |
Why?
|
Drug Implants | 2 | 2018 | 230 | 0.050 |
Why?
|
Child | 6 | 2020 | 80969 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2560 | 0.050 |
Why?
|
Fat Necrosis | 2 | 2013 | 60 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2006 | 649 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4432 | 0.050 |
Why?
|
Staining and Labeling | 1 | 2005 | 1081 | 0.050 |
Why?
|
Students | 1 | 2011 | 1744 | 0.050 |
Why?
|
Adipogenesis | 2 | 2014 | 371 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2017 | 1049 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2007 | 3102 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39394 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 487 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2006 | 1027 | 0.040 |
Why?
|
Up-Regulation | 2 | 2006 | 4148 | 0.040 |
Why?
|
Necrosis | 2 | 2018 | 1621 | 0.040 |
Why?
|
Tamoxifen | 1 | 2005 | 967 | 0.040 |
Why?
|
Neutropenia | 1 | 2005 | 893 | 0.040 |
Why?
|
Transfection | 2 | 2018 | 5763 | 0.040 |
Why?
|
Aged | 6 | 2021 | 171790 | 0.040 |
Why?
|
Inflammation | 2 | 2018 | 10869 | 0.040 |
Why?
|
Swine | 2 | 2021 | 5998 | 0.040 |
Why?
|
Middle Aged | 7 | 2018 | 223740 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8384 | 0.040 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2021 | 254 | 0.040 |
Why?
|
Estrogens | 2 | 2022 | 1537 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1673 | 0.040 |
Why?
|
Neovascularization, Physiologic | 2 | 2021 | 1371 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2941 | 0.040 |
Why?
|
Ink | 1 | 2018 | 47 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 418 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2016 | 1714 | 0.040 |
Why?
|
Suction | 1 | 2018 | 268 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6293 | 0.040 |
Why?
|
Tissue Expansion | 1 | 2018 | 163 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 30044 | 0.040 |
Why?
|
Cohort Studies | 2 | 2018 | 41800 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 18 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2018 | 278 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 2018 | 193 | 0.030 |
Why?
|
Anniversaries and Special Events | 1 | 2017 | 97 | 0.030 |
Why?
|
Biliopancreatic Diversion | 1 | 2015 | 15 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2018 | 1769 | 0.030 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2016 | 110 | 0.030 |
Why?
|
France | 1 | 2017 | 497 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5956 | 0.030 |
Why?
|
Receptors, Steroid | 1 | 2016 | 156 | 0.030 |
Why?
|
Program Development | 2 | 2013 | 1300 | 0.030 |
Why?
|
Esthetics | 1 | 2017 | 330 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12252 | 0.030 |
Why?
|
Platelet-Rich Plasma | 1 | 2018 | 180 | 0.030 |
Why?
|
Stem Cell Transplantation | 2 | 2014 | 1602 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3283 | 0.030 |
Why?
|
CA1 Region, Hippocampal | 1 | 2016 | 110 | 0.030 |
Why?
|
Needs Assessment | 2 | 2012 | 1142 | 0.030 |
Why?
|
Body Surface Area | 1 | 2015 | 206 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1952 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3591 | 0.030 |
Why?
|
Cell Lineage | 2 | 2014 | 2576 | 0.030 |
Why?
|
Cold Temperature | 1 | 2018 | 791 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2016 | 369 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 501 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5800 | 0.030 |
Why?
|
Time | 1 | 2016 | 552 | 0.030 |
Why?
|
Protein Stability | 1 | 2016 | 580 | 0.030 |
Why?
|
Infant | 4 | 2020 | 36541 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2016 | 290 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2014 | 55 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 244 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1890 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2015 | 479 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1830 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 351 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 93 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10778 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 59738 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9564 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1169 | 0.030 |
Why?
|
Pyramidal Cells | 1 | 2016 | 367 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 348 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 5905 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2784 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1162 | 0.030 |
Why?
|
Efficiency | 1 | 2016 | 480 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1382 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2023 | 81892 | 0.030 |
Why?
|
Neutrophils | 1 | 2005 | 3785 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4265 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1124 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2488 | 0.030 |
Why?
|
Heart Failure | 1 | 2016 | 11879 | 0.020 |
Why?
|
Work Schedule Tolerance | 1 | 2016 | 553 | 0.020 |
Why?
|
Homozygote | 1 | 2016 | 1779 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22390 | 0.020 |
Why?
|
Burns, Chemical | 1 | 2012 | 123 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1667 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2395 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2016 | 1177 | 0.020 |
Why?
|
Risk Factors | 1 | 2017 | 74971 | 0.020 |
Why?
|
Hernia, Abdominal | 1 | 2010 | 58 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2663 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 240 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2014 | 1866 | 0.020 |
Why?
|
Haiti | 1 | 2010 | 553 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2472 | 0.020 |
Why?
|
Cell Separation | 1 | 2014 | 1728 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1904 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2835 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2006 | 22294 | 0.020 |
Why?
|
Risk Assessment | 3 | 2017 | 24330 | 0.020 |
Why?
|
Leptin | 1 | 2015 | 1597 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1752 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21545 | 0.020 |
Why?
|
Aorta | 2 | 2005 | 2046 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1675 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5794 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2010 | 316 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2277 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6320 | 0.020 |
Why?
|
Glucose | 1 | 2018 | 4352 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3782 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1264 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 886 | 0.020 |
Why?
|
Cricetulus | 1 | 2007 | 813 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 26394 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2537 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 618 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 17174 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2014 | 2395 | 0.020 |
Why?
|
Amitrole | 1 | 2005 | 8 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2005 | 57 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2005 | 150 | 0.020 |
Why?
|
CHO Cells | 1 | 2007 | 1380 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2862 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5801 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2012 | 1839 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2231 | 0.010 |
Why?
|
Critical Care | 1 | 2017 | 2715 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 536 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2010 | 971 | 0.010 |
Why?
|
Device Removal | 1 | 2009 | 643 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4207 | 0.010 |
Why?
|
Skin | 1 | 2018 | 4507 | 0.010 |
Why?
|
Cricetinae | 1 | 2007 | 2423 | 0.010 |
Why?
|
Echocardiography | 1 | 2016 | 5046 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1184 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 926 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 605 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 297 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4032 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9375 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4415 | 0.010 |
Why?
|
Dogs | 1 | 2007 | 3845 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3613 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20776 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 6991 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2007 | 2695 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2015 | 3800 | 0.010 |
Why?
|
Low Back Pain | 1 | 2010 | 990 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1956 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2007 | 864 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6525 | 0.010 |
Why?
|
Cost of Illness | 1 | 2011 | 1959 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10641 | 0.010 |
Why?
|
Cell Communication | 1 | 2007 | 1660 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5707 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18454 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13510 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2011 | 1941 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16735 | 0.010 |
Why?
|
Health Policy | 1 | 2011 | 2700 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4593 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7860 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5035 | 0.010 |
Why?
|
Protein Binding | 1 | 2007 | 9344 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 30175 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 13087 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2011 | 5520 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15955 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54950 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30266 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26384 | 0.010 |
Why?
|